ketamine has been researched along with Atherosclerotic Parkinsonism in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verma, A | 1 |
| Kulkarni, SK | 1 |
| Kucheryanu, VG | 1 |
| Kryzhanovskii, GN | 1 |
| Onofrj, M | 1 |
| Ghilardi, MF | 1 |
| Basciani, M | 1 |
| Martinez-Tica, J | 1 |
| Glover, A | 1 |
3 other studies available for ketamine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Catalepsy; Dizocilpine Maleate; Haloperido | 1995 |
Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Excitatory Amino Acid Antagonists; Glutamic A | 2000 |
Attenuation of the early anterior negativity of median nerve somatosensory evoked potential in the MPTP-treated monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Electric Stimulation; Evoked Potentials, Soma | 1990 |